431 filings
Page 16 of 22
8-K
37exz26cc3c0 2osi
27 Sep 16
Onconova Announces Successful End-of-Phase 2 Meeting with FDA for Oral Rigosertib and Azacitidine Combination
12:00am
8-K
aqarblmqmffgeiq vpf
30 Aug 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
b2u6iv
15 Aug 16
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2016 Financial Results
12:00am
8-A12B
wh4lvk856 lp7dbvdg2
27 Jul 16
Registration of securities on exchange
12:00am
424B3
a6752ei
22 Jul 16
Prospectus supplement
12:00am
8-K
fayw699h
13 Jul 16
Entry into a Material Definitive Agreement
12:00am
424B4
jq3ly qyc
8 Jul 16
Prospectus supplement with pricing info
12:00am
EFFECT
byofgwo2p
7 Jul 16
Notice of effectiveness
12:00am
CORRESP
6piqy 24c01r8ouh7
5 Jul 16
Correspondence with SEC
12:00am
FWP
wdo4cc7097if
20 Jun 16
Free writing prospectus
12:00am
UPLOAD
5o9fsr
14 Jun 16
Letter from SEC
12:00am
8-K
psvp0ai5sss9uoj
31 May 16
Material Modifications to Rights of Security Holders
12:00am
8-K
fdrm5zob3d2a8xtmf
23 May 16
Submission of Matters to a Vote of Security Holders
12:00am